Rainer Spanagel is a German scientist, born June 24, 1961. [1] He is a professor of psychopharmacology at the Central Institute of Mental Health (Mannheim) of Heidelberg University, where he is director of the Institute of Psychopharmacology. [2] [3] His main research interest is drug abuse, especially alcohol dependence. [3] [4] His work has been published in multiple publications across prestigious scientific journals. [1]
Based on preclinical findings, he pursues three objectives along with other faculty at the Central Institute of Mental Health: [1]
1) The development of new behavioral therapies, pharmacological interventions, and neuromodulatory approaches in addicted patients.
2) To clarify the neurobiological long-term consequences of drug abuse and binge drinking in adolescents
3) The identification of risk factors for addictive disorders and development of preventive strategies.
General field of study: Psychopharmacology, Addiction Research, Alcohol Abuse
Spanagel completed his undergraduate studies in Biology at the Universities of Tübingen and Munich (1983-1989) and his Ph.D. in Neuropharmacology from the Max Planck Institute of Neuropharmacology (Martinsried, Germany), working under Prof. Albert Herz (1991). [1] In 1989, he obtained his Diploma in Neuropharmacology from the Max Planck Institute of Neuropharmacology (Martinsried, Germany). [1] He followed up with his post-doctoral training with Prof. Wolfgang Forth in the Habilitation, Pharmacology & Toxicology Department at the University of Munich (Munich, Germany) in 1996. [1]
Spanagel is highly accomplished and has received multiple awards and honors: [1]
{{cite web}}
: CS1 maint: archived copy as title (link)